The Global market for Leukemia Therapeutics is expected to reach $11.2 billion by the end of 2020 growing at a CAGR of around 4.7% from 2014 to 2021. Leukemia is a form of cancer which occurs when there is an excess of abnormal white blood cells in the blood. Under normal conditions, the blood forming cells of the bone marrow produce leukocytes for defense against viruses and bacteria. If the leukocytes are damaged and if they remained untreated they get accumulated in the body. The untreated c Mehr anzeigen
